CARLA FIORENTINI is presently Director of Preclinical Research at the Association for Research of Integrative Oncology Therapies (ARTOI). She was Director of the “Natural Substances, Traditional Medicine” Section at the Dept. of Therapeutic Research and Medicines Evaluation, and Coordinator of a Research Group at the Italian Center for Global Health, Istituto Superiore di Sanità (ISS), Roma. She has an Academic Degree in Biology and Specialty in Microbiology, University of Roma. Post-doctoral training was performed at Karolinska Institutet, Stockholm, Sweden. Her current research is focused on unraveling the role of bacterial protein toxins in cancer and on the use the bacterial toxin CNF1 as a potential novel therapeutic for central nervous system disorders. She is co-inventor in five different patents on CNF1 activity on the central nervous system. As co-author of numerous book chapters and articles in leading journals, she is renowned in the field of bacterial protein toxins.